Elevated serum levels of S100A8/A9 and HMGB1 at hospital admission are correlated with inferior clinical outcomes in COVID-19 patients

Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study

(2020) Yingzhen Du et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2: A systematic review and meta-analysis

(2020) Yinghao Cao et al.   JOURNAL OF MEDICAL VIROLOGY

Covid-19: WHO declares pandemic because of “alarming levels” of spread, severity, and inaction

(2020) Elisabeth Mahase   BMJ-British Medical Journal

Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19

(2020) Wenhua Liang et al.   JAMA Internal Medicine

Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income Countries

(2018) Kristina E. Rudd et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

DAMPs from Cell Death to New Life

(2015) Emilie Vénéreau et al.   Frontiers in Immunology

The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis

(2014) Peter Huebener et al.   JOURNAL OF CLINICAL INVESTIGATION

Inhibition of extracellular HMGB1 attenuates hyperoxia-induced inflammatory acute lung injury

(2014) Maria Entezari et al.   Redox Biology

Alarmins: awaiting a clinical response

(2012) James K. Chan et al.   JOURNAL OF CLINICAL INVESTIGATION